Review
Copyright ©The Author(s) 2017.
World J Transplant. Dec 24, 2017; 7(6): 285-300
Published online Dec 24, 2017. doi: 10.5500/wjt.v7.i6.285
Table 1 Prevalence of the de novo vs recurrent membranoproliferative glomerulonephritis according to the new membranoproliferative glomerulonephritis pathological classification depending on the mechanism of glomerular injury instead of deposits distribution[14,59]
No.MPGN subtypePathological criteriaRecurrent MPGNDe novo MPGN
1ICGN (immune complex-mediated GN)Contains immune complexes + complement compoundsMore common (most of the recurrent cases are ICGN)Reported (3.25%)
2CGN (complement-mediated GN)Contains complement compounds onlyLess prevalent (change from one type to another)Not reported (Ponticelli et al[14], 2014)